Hackensack Meridian to Deploy Lumeris’ AI Tool in MSSP ACO
Lumeris says ‘Tom’ platform to enable tracking, performance management, and scalable best-next-action workflows embedded in clinical operations
Lumeris says ‘Tom’ platform to enable tracking, performance management, and scalable best-next-action workflows embedded in clinical operations
Experts say Hims & Hers’ acquisition of Eucalyptus positions the company for global expansion and revenue diversification amid U.S. GLP-1 regulatory challenges. The post What Experts Say About Hims & Hers’ $1.15B Acquisition of Eucalyptus appeared first on MedCity News.
Ensuring that family caregivers, and hospice providers all get the support that they need is more than just about ensuring that a patient receives end-of-life care with the dignity and support they deserve. The post Family Caregivers Deserve to be a Valued Part of the Healthcare Continuum appeared first on MedCity News.
States and the nation’s health industry were thrown into disarray after the Trump administration ordered Monday that the government freeze nearly all federal grants at 5 p.m. ET Tuesday, a sweeping directive that at least initially appeared to include funding for Medicaid, the state-federal health insurance program that covers more than 70 million Americans. By…
The proliferation and rapid adoption of AVT in clinical settings has not gone unnoticed, and NHS England has made it clear that the use of these tools must now meet stringent compliance standards. The post Rush To Regulation: What New NHS Compliance Requirements For Ambient Voice Technology Mean For US Providers appeared first on MedCity…
Now is the time to build a system where every pregnant person, regardless of zip code, ethnicity, or insurance status, can access the level of care their pregnancy demands. The post The U.S. Keeps Failing the March of Dimes Report Card. Here’s One Gap We Can Close Right Now appeared first on MedCity News.
Execs from Future Communities Institute, Akido Labs describe potential of technology-based program under CalAIM
This brief looks at premium changes for Medicare Part D stand-alone prescription drug plans between 2025 and 2026. For plans that were offered nationwide in 2025 and will continue to be offered in 2026, Part D enrollees in many states will see lower monthly premiums in 2026.
Health systems across the country are launching enterprise-wide deployments of AI-powered clinical documentation tools. Hospital leaders agree that this technology reduces physician burnout, as well as allows physicians to have more meaningful and productive interactions with patients. The post Which Clinical Documentation AI Tools Are Health Systems Using? appeared first on MedCity News.
Sidewinder Therapeutics and Stipple Bio each raised mega-rounds of financing to support their approaches to improving the targeting abilities of antibody drug conjugates for cancer. Both startups are on track to enter the clinic next year. The post Two New Takes on Making a Type of Targeted Cancer Therapy Even Better appeared first on MedCity…